ACHE and myeloid sarcoma: Although, to date, there are not sufficient data in MS patients on the use of AChE inhibitors [42,43], it is known that EAE mice chronically treated with AChE inhibitors present amelioration of the disease symptoms and reduction of neuroinflammation and demyelination [27].